← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2010Last known activity
Mar 19, 2020
Timeline
1940s
- Jun 1, 1946
Kosin University— Founded
Drugs by trial phase (38 distinct, 20 trials)
Phase 4 (8 own, 0 via acquisition)
Phase 3 (5 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Adenocarcinoma of Lung
- Angina Pectoris, Variant
- Arthritis
- Arthritis, Rheumatoid
- Breast Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Crohn Disease
- Diabetes Mellitus
- Edema
- Essential Hypertension
- Hypertension
- Influenza, Human
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Mantle-Cell
- Macular Edema
- Multiple Myeloma
- Neoplasms, Plasma Cell
- Stomach Neoplasms
- Waldenstrom Macroglobulinemia
- Wounds and Injuries
Recent trials (30)
- NCT05051332Overall official - principal investigatorPhase 3Mar 19, 2020
- NCT04214990CollaboratorPhase 3Jan 15, 2020
- NCT03809780Reponsible party - principal investigatorPhase 2Feb 1, 2019
- NCT03809780Lead sponsorPhase 2Feb 1, 2019
- NCT03760133Reponsible party - principal investigatorPhase 2Nov 23, 2018
- NCT03760133Lead sponsorPhase 2Nov 23, 2018
- NCT03697356Reponsible party - principal investigatorPhase 2Oct 1, 2018
- NCT03697356Lead sponsorPhase 2Oct 1, 2018
- NCT03616782Lead sponsorPhase 2Aug 30, 2018
- NCT03616782Sponsor investigatorPhase 2Aug 30, 2018
- NCT03616782Overall official - principal investigatorPhase 2Aug 30, 2018
- NCT03054467Lead sponsorPhase 4May 1, 2017
- NCT03054467Reponsible party - principal investigatorPhase 4May 1, 2017
- NCT03465527Lead sponsorPhase 2Apr 13, 2017
- NCT03465527Reponsible party - principal investigatorPhase 2Apr 13, 2017
Details
- Founded
- Busan, KR Jun 1, 1946
- Last known activity
- Mar 19, 2020